Terumo Cardiovascular Systems to sell Vascutek® Vascular Grafts in the US
ANN ARBOR, Michigan — April 1, 2007 — Terumo Cardiovascular Systems is pleased to announce that effective April 1, 2007, it will assume responsibility for direct sales and support of Vascutek vascular grafts in the US.
Vascutek USA and Terumo Cardiovascular Systems are subsidiaries of Terumo Corporation and are both headquartered in the same building in Ann Arbor, Michigan. Vascutek Ltd. of Renfrewshire, Scotland, also a Terumo company, continues to develop and manufacture vascular products for global distribution and is responsible for all sales and support outside of the US.
This opportunity will enable Vascutek to take advantage of Terumo Cardiovascular Systems' nationally established sales and support network in the US cardiac and vascular surgery markets.
# # #
Terumo Cardiovascular Systems Corporation manufactures and markets medical devices for the global cardiac surgery and interventional markets. The company is headquartered in Ann Arbor, Michigan with manufacturing operations in Ann Arbor; Elkton, Maryland; Ashland, Massachusetts; and Tustin, California. It is one of several subsidiaries of Terumo Corporation of Japan focused exclusively on the cardiac and vascular markets, including Terumo Heart Inc., developer of a ventricular assist device. For more information, visit www.terumo-cvs.com.
Terumo Corporation is a premier global medical device company with 2005 annual sales in excess of $2.3 billion. Founded in 1921, the company develops, manufactures and distributes world-class medical devices for use in cardiothoracic surgery, interventional procedures, transfusion medicine, and needle and syringe products. Terumo contributes to society by providing valued products and services in the healthcare market and by responding to the needs of healthcare providers and the people they serve. Terumo Corporation's shares are listed on the first section of the Tokyo Stock Exchange (No. 4543, Reuters symbol <4543.T>, or Bloomberg 4543:JP). They are a component of the Nikkei 225, Japan's leading stock index.
Based in Renfrewshire, Scotland, Vascutek Ltd. uses innovative vascular technologies to develop products that address the needs of cardiac and vascular surgeons throughout the world. Founded in 1982, Vascutek was one of the first medical device manufacturers to affix the CE mark to its products. The company was acquired by Terumo Corporation in 2002. Vascutek is guided by an ethos of technical excellence, stringent quality control and total customer service. For more information, visit www.vascutek.com.